About the Company
athersys is a clinical stage biopharmaceutical company with a growing pipeline of highly differentiated, potential best in class therapeutics to treat significant and life-threatening diseases. we are engaged in the discovery and development of innovative new medicines designed to extend and enhance the quality of human life. through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas. this pipeline includes both stem cell therapy and pharmaceuticals.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $ATHX News
Athersys Inc ATHXQ
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Why Athersys Shares Are Falling During Tuesday's Session
Athersys Inc (NASDAQ: ATHX) shares are trading lower by 12.94% to $0.98 Tuesday morning. The company announced a $3.7 million registered direct offering and concurrent private placement.
Athersys Inc Stock (OTC:ATHX), Insider Trading Activity
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades ...
Athersys, Inc. Common Stock (ATHX)
Call and put options are quoted in a table called a chain sheet. The chain sheet shows the price, volume and open interest for each option strike price and expiration month. Nasdaq provides call ...
Athersys Goes Public Through Reverse Merger, Raises $65M
Shares of Corbus Pharmaceuticals Inc. (NASDAQ:CRBP) doubled on opening Jan. 26 and ended the day up a whopping 249% as investors got a look at data from a ...
Athersys (ATHX) Stock Plummets to 52-Week Low as Stroke Therapy Fails Mid-Stage Trial
Shares of Athersys (ATHX) plunged more than 55% to a one-year low of 90 cents on Friday after the biotech company's stem-cell therapy to treat strokes failed a mid-stage study. Shares of Athersys ...
Here’s Why Athersys (ATHX) Stock is Jumping Today
Athersys (ATHX) stock is up after the company announced positive results from the analysis of one year follow-up data from a Phase 2 study of its therapy for ischemic strokes. Athersys (ATHX ...
Athersys (ATHXQ) Earnings Dates & Reports
View upcoming earnings forecasts and in-depth analysis of company forecasts.
Evelo Biosciences, Inc. (EVLO)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Search Results
Crafts retailer Joann Inc. has added an expert at turning around companies to its board amid reports of impending bankruptcy.… Commercial tenants continue to be interested in leasing downtown ...
Athersys, Inc. (ATHXQ)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Loading the latest forecasts...